TaiShang
ELITE MEMBER
- Joined
- Apr 30, 2014
- Messages
- 27,848
- Reaction score
- 70
- Country
- Location
China's listed companies invest heavily in R&D in 2018
Xinhua | Updated: 2019-04-12
People visit the AI interaction area at the China Beijing International High-Tech Expo (CHITEC) on May 17, 2018. [Photo/VCG]
BEIJING - Listed companies in China saw robust growth in research and development (R&D) investment in 2018, according to financial data analyzer Wind.
A total of 1,178 listed companies disclosed their 2018 R&D information by Thursday, spending 384.7 billion yuan ($7.2 billion) last year, up 23.72 percent year-on-year.
About 81 percent of the companies invested more in R&D than in 2017, and 85 companies doubled their R&D expenditures.
Companies in oil exploration, infrastructure and electronics manufacturing led R&D spending, while investment in emerging industries like computers, semiconductors and biomedicine accounted for a relatively larger proportion of revenue.
Increases in R&D personnel became one of the main drivers for the substantial increase in R&D investment, with the number of R&D professionals in 728 listed companies taking up more than 10 percent of their total employees.
http://www.chinadaily.com.cn/a/201904/12/WS5cb042ffa3104842260b5ea7.html
Xinhua | Updated: 2019-04-12
People visit the AI interaction area at the China Beijing International High-Tech Expo (CHITEC) on May 17, 2018. [Photo/VCG]
BEIJING - Listed companies in China saw robust growth in research and development (R&D) investment in 2018, according to financial data analyzer Wind.
A total of 1,178 listed companies disclosed their 2018 R&D information by Thursday, spending 384.7 billion yuan ($7.2 billion) last year, up 23.72 percent year-on-year.
About 81 percent of the companies invested more in R&D than in 2017, and 85 companies doubled their R&D expenditures.
Companies in oil exploration, infrastructure and electronics manufacturing led R&D spending, while investment in emerging industries like computers, semiconductors and biomedicine accounted for a relatively larger proportion of revenue.
Increases in R&D personnel became one of the main drivers for the substantial increase in R&D investment, with the number of R&D professionals in 728 listed companies taking up more than 10 percent of their total employees.
http://www.chinadaily.com.cn/a/201904/12/WS5cb042ffa3104842260b5ea7.html
